MSFT 447.67 -0.4691% AAPL 208.14 0.3133% NVDA 118.11 -6.684% GOOGL 179.22 -0.2282% GOOG 180.79 0.294% AMZN 185.57 -1.8564% META 498.91 0.8347% AVGO 1592.21 -4.0045% TSLA 182.58 -0.235% TSM 167.81 -3.5353% LLY 890.11 0.7048% V 276.3 0.3924% JPM 198.88 1.3143% UNH 489.98 1.5313% NVO 142.28 0.2254% WMT 68.9 1.4578% LVMUY 155.41 1.3169% XOM 114.04 2.9614% LVMHF 780.0 1.9608% MA 456.96 0.4639%

Medtronic PLC

Healthcare US MDT


Last update at 2024-06-24T20:10:00Z

Day Range


52 Week Range



  • Previous Close 81.64
  • Market Cap108978.18M
  • Volume6756382
  • P/E Ratio26.60
  • Dividend Yield3.37%
  • EBITDA8484.00M
  • Revenue TTM31958.00M
  • Revenue Per Share TTM24.02
  • Gross Profit TTM 21715.00M
  • Diluted EPS TTM3.08


Income Statement


Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Income before tax 5364.00M 5517.00M 3895.00M 4055.00M 5197.00M
Minority interest -26.00000M -22.00000M 174.00M 17.00M 121.00M
Net income 3758.00M 5039.00M 3606.00M 4789.00M 4631.00M
Selling general administrative 10415.00M 10292.00M 10148.00M 9875.00M 10232.00M
Selling and marketing expenses - - - - -
Gross profit 20508.00M 21541.00M 19634.00M 19489.00M 21402.00M
Reconciled depreciation 2697.00M 2707.00M 2702.00M 2663.00M 2659.00M
Ebit 5485.00M 5752.00M 4484.00M 4791.00M 7005.00M
Ebitda 9042.00M 8932.00M 7933.00M 8241.00M 9664.00M
Depreciation and amortization 3557.00M 3180.00M 3449.00M 3450.00M 2659.00M
Non operating income net other 515.00M 318.00M 336.00M 356.00M 373.00M
Operating income 5485.00M 5752.00M 4484.00M 4791.00M 6268.00M
Other operating expenses 25397.00M 25778.00M 25222.00M 23691.00M 23925.00M
Interest expense 636.00M 553.00M 925.00M 1092.00M 1444.00M
Tax provision 1580.00M 456.00M 265.00M -751.00000M 547.00M
Interest income 164.00M 541.00M 617.00M 379.00M 676.00M
Net interest income -636.00000M -553.00000M -925.00000M -1092.00000M -1444.00000M
Extraordinary items - - 106.00M 63.00M -12.00000M
Non recurring -30.00000M 95.00M 118.00M 313.00M 166.00M
Other items - - - - 0.00000M
Income tax expense 1580.00M 456.00M 265.00M -751.00000M 547.00M
Total revenue 31227.00M 31686.00M 30117.00M 28913.00M 30557.00M
Total operating expenses 14678.00M 15633.00M 14739.00M 14267.00M 14770.00M
Cost of revenue 10719.00M 10145.00M 10483.00M 9424.00M 9155.00M
Total other income expense net -121.00000M -235.00000M -589.00000M -736.00000M 9.00M
Discontinued operations - - - - 0.00000M
Net income from continuing ops 3784.00M 5062.00M 3630.00M 4806.00M 4650.00M
Net income applicable to common shares 3758.00M 5039.00M 3606.00M 4789.00M 4631.00M
Preferred stock and other adjustments - - - - -
Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Total assets 90948.00M 90981.00M 93083.00M 90689.00M 89694.00M
Intangible assets 14844.00M 15595.00M 17740.00M 19063.00M 20560.00M
Earning assets - - - - -
Other current assets 2425.00M 2319.00M 1956.00M 2209.00M 2144.00M
Total liab 39283.00M 38259.00M 41481.00M 39817.00M 39482.00M
Total stockholder equity 51483.00M 52551.00M 51428.00M 50737.00M 50091.00M
Deferred long term liab 708.00M 884.00M 1028.00M 1174.00M 1278.00M
Other current liab 6369.00M 6376.00M 6392.00M 5594.00M 5681.00M
Common stock 0.13M 0.13M 0.13M 0.13M 0.13M
Capital stock 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Retained earnings 30392.00M 30250.00M 28594.00M 28132.00M 26270.00M
Other liab 6771.00M 5493.00M 5765.00M 6656.00M 6524.00M
Good will 41425.00M 40502.00M 41961.00M 39841.00M 39959.00M
Other assets -1.00000M 1.00M 1.00M 3486.00M 2108.00M
Cash 1543.00M 3714.00M 3593.00M 4140.00M 4393.00M
Cash and equivalents 1543.00M 3714.00M 3593.00M 4140.00M 4393.00M
Total current liabilities 9051.00M 12394.00M 8509.00M 10366.00M 8472.00M
Current deferred revenue - - - - 315.00M
Net debt 22821.00M 20400.00M 22796.00M 20657.00M 20931.00M
Short term debt 20.00M 3742.00M 11.00M 2776.00M 838.00M
Short long term debt 20.00M 3742.00M 11.00M 2771.00M 832.00M
Short long term debt total 24364.00M 24114.00M 26389.00M 24797.00M 25324.00M
Other stockholder equity 24590.00M 24566.00M 26319.00M 26165.00M 26532.00M
Property plant equipment 6610.00M 5413.00M 6219.00M 4828.00M 4675.00M
Total current assets 21675.00M 23059.00M 22548.00M 22031.00M 21967.00M
Long term investments - - - - 416.00M
Net tangible assets 51483.00M -3546.00000M -8273.00000M 50737.00M -10428.00000M
Short term investments 6416.00M 6859.00M 7224.00M 6808.00M 5455.00M
Net receivables 5998.00M 5551.00M 5462.00M 4645.00M 6222.00M
Long term debt 24344.00M 20372.00M 26378.00M 21976.00M 24476.00M
Inventory 5293.00M 4616.00M 4313.00M 4229.00M 3753.00M
Accounts payable 2662.00M 2276.00M 2106.00M 1996.00M 1953.00M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity 182.00M 171.00M 174.00M 135.00M 121.00M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income -3499.00000M -2265.00000M -3485.00000M -3560.00000M -2711.00000M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - - - 0.00000M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity 30392.00M 30250.00M 28594.00M 28132.00M 26270.00M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - -
Non currrent assets other 7436.00M 6411.00M 5612.00M 4926.00M 2533.00M
Deferred long term asset charges - - - - -
Non current assets total 69274.00M 67921.00M 70534.00M 68658.00M 67727.00M
Capital lease obligations 64.00M 62.00M 71.00M 50.00M 16.00M
Long term debt total 24344.00M 20372.00M 26378.00M 22021.00M 24486.00M
Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Investments -3493.00000M -190.00000M -463.00000M -1465.00000M 2532.00M
Change to liabilities 696.00M 213.00M 531.00M -44.00000M 399.00M
Total cashflows from investing activities -3493.00000M -1659.00000M -2866.00000M -3203.00000M -774.00000M
Net borrowings -598.00000M -1.00000M -570.00000M -559.00000M -713.00000M
Total cash from financing activities -4960.00000M -5336.00000M -4136.00000M -4198.00000M -5431.00000M
Change to operating activities - -65.00000M -549.00000M -609.00000M -624.00000M
Net income 3784.00M 5062.00M 3630.00M 4806.00M 4650.00M
Change in cash -2171.00000M 121.00M -547.00000M -253.00000M 724.00M
Begin period cash flow 3714.00M 3593.00M 4140.00M 4393.00M 3669.00M
End period cash flow 1543.00M 3714.00M 3593.00M 4140.00M 4393.00M
Total cash from operating activities 6039.00M 7346.00M 6240.00M 7234.00M 7007.00M
Issuance of capital stock 308.00M 429.00M 474.00M 662.00M 992.00M
Depreciation 2697.00M 2707.00M 2702.00M 2663.00M 2659.00M
Other cashflows from investing activities -1863.00000M -10.00000M -54.00000M -525.00000M 1827.00M
Dividends paid -3616.00000M -3383.00000M -3121.00000M -2894.00000M 2693.00M
Change to inventory -939.00000M -560.00000M 78.00M -577.00000M -274.00000M
Change to account receivables -576.00000M -477.00000M -761.00000M 1291.00M -581.00000M
Sale purchase of stock -645.00000M -2544.00000M -652.00000M -1326.00000M -2877.00000M
Other cashflows from financing activities 7284.00M 163.00M 9694.00M 5470.00M 7095.00M
Change to netincome 525.00M 489.00M 633.00M -296.00000M 778.00M
Capital expenditures 1459.00M 1368.00M 1355.00M 1213.00M 1134.00M
Change receivables -576.00000M -477.00000M -761.00000M 1291.00M -581.00000M
Cash flows other operating -148.00000M -65.00000M -549.00000M -609.00000M -624.00000M
Exchange rate changes - - - - -
Cash and cash equivalents changes -2414.00000M 351.00M -762.00000M -167.00000M 802.00M
Change in working capital -967.00000M -889.00000M -701.00000M 61.00M -1080.00000M
Stock based compensation 355.00M 359.00M 344.00M 297.00M 290.00M
Other non cash items 396.00M 711.00M 687.00M 722.00M 792.00M
Free cash flow 4580.00M 5978.00M 4885.00M 6021.00M 5873.00M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
Medtronic PLC
-0.6 0.73% 81.04 26.60 15.87 3.35 2.08 3.90 14.12
Abbott Laboratories
-0.42 0.40% 105.30 37.15 23.15 4.67 4.97 4.88 19.38
Stryker Corporation
-3.57 1.04% 339.07 44.07 24.94 5.51 6.12 6.05 25.73
Boston Scientific Corp
-1.0 1.29% 76.71 68.17 24.57 5.85 4.26 6.46 26.80
Siemens Healthineers AG
- -% 58.00 39.57 21.32 3.01 3.29 2.95 16.92

Reports Covered

Stock Research & News


Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Medtronic PLC

20 On Hatch, Dublin, Ireland, 2

Key Executives

Name Title Year Born
Mr. Geoffrey Straub Martha Chairman & CEO 1970
Ms. Karen L. Parkhill EVP, CFO, IT & Enterprise Excellence 1965
Mr. Ivan K. Fong Exec. VP, Gen. Counsel & Sec. 1961
Mr. Robert J. W. ten Hoedt Exec. VP & Pres of Global Regions 1960
Mr. Robert John White Exec. VP & Pres of Medical Surgical Portfolio 1963
Mr. Mark Ploof Sr. VP of Global Operations and Bus. Services NA
Ms. Jennifer M. Kirk Principal Accounting Officer, Global Controller & Chief Accounting Officer 1975
Dr. Laura Mauri M.D., M.Sc. Sr. VP and Chief Scientific, Medical & Regulatory Officer NA
Mr. Sean Lennon Chief Information Officer NA
Mr. Ryan Weispfenning VP of Investor Relations NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).